Tools to fight hantavirus show promise despite limited funding. Now researchers hope to continue
• Researchers, including Dr. Paul Bollyky of Stanford Medical Center, are struggling to secure funding and infrastructure to develop vaccines and treatments for the hantavirus. • The lack of medical countermeasures was highlighted during a recent hantavirus outbreak on a cruise ship, where no preventative tools were available. • Development is hindered by the virus's sporadic nature and the rarity of infections, which makes conducting large-scale clinical trials significantly more difficult than for common germs like the flu.
ny1.com











